132 related articles for article (PubMed ID: 8391870)
41. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
42. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
[TBL] [Abstract][Full Text] [Related]
43. The Ca2+-mobilizing potency of alpha-thrombin and thrombin-receptor-activating peptide on human platelets -- concentration and time effects of thrombin-induced Ca2+ signaling.
Heemskerk JW; Feijge MA; Henneman L; Rosing J; Hemker HC
Eur J Biochem; 1997 Oct; 249(2):547-55. PubMed ID: 9370366
[TBL] [Abstract][Full Text] [Related]
44. The role of PAR4 in thrombin-induced thromboxane production in human platelets.
Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Teng CM
Thromb Haemost; 2003 Aug; 90(2):299-308. PubMed ID: 12888878
[TBL] [Abstract][Full Text] [Related]
45. Inhibition and potentiation of platelet function by lysolecithin.
Joist JH; Dolezel G; Cucuianu MP; Nishizawa EE; Mustard JF
Blood; 1977 Jan; 49(1):101-12. PubMed ID: 830368
[TBL] [Abstract][Full Text] [Related]
46. Differences between platelet phosphoinositide metabolism stimulated by thrombin or SFLLRN are not accounted for by interaction of thrombin with glycoprotein Ib.
Vickers JD; Packham MA; Kinlough-Rathbone RL
Am J Hematol; 1997 Apr; 54(4):288-95. PubMed ID: 9092683
[TBL] [Abstract][Full Text] [Related]
47. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.
Quinton TM; Kim S; Derian CK; Jin J; Kunapuli SP
J Biol Chem; 2004 Apr; 279(18):18434-9. PubMed ID: 14973136
[TBL] [Abstract][Full Text] [Related]
48. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
49. Conditions influencing platelet lysis.
Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
[TBL] [Abstract][Full Text] [Related]
50. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.
Suidan HS; Clemetson KJ; Brown-Luedi M; Niclou SP; Clemetson JM; Tschopp J; Monard D
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):939-45. PubMed ID: 8645180
[TBL] [Abstract][Full Text] [Related]
51. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
52. Response of blood leukocytes to thrombin receptor peptides.
Hoffman M; Church FC
J Leukoc Biol; 1993 Aug; 54(2):145-51. PubMed ID: 8395550
[TBL] [Abstract][Full Text] [Related]
53. Measurement of fibrinogen concentrations in suspensions of washed rabbit and human platelets by radioimmunoassays.
Harfenist EJ; Wrana JL; Packham MA; Mustard JF
Thromb Haemost; 1985 Feb; 53(1):110-5. PubMed ID: 3992511
[TBL] [Abstract][Full Text] [Related]
54. Mammalian platelet adrenoceptors.
Kerry R; Scrutton MC; Wallis RB
Br J Pharmacol; 1984 Jan; 81(1):91-102. PubMed ID: 6322894
[TBL] [Abstract][Full Text] [Related]
55. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets.
Murugappan S; Tuluc F; Dorsam RT; Shankar H; Kunapuli SP
J Biol Chem; 2004 Jan; 279(4):2360-7. PubMed ID: 14578358
[TBL] [Abstract][Full Text] [Related]
56. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.
Packham MA; Kinlough-Rathbone RL; Mustard JF
Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698
[TBL] [Abstract][Full Text] [Related]
57. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
Cattaneo M; Canciani MT; Lecchi A; Kinlough-Rathbone RL; Packham MA; Mannucci PM; Mustard JF
Blood; 1990 Mar; 75(5):1081-6. PubMed ID: 2137716
[TBL] [Abstract][Full Text] [Related]
58. The use of the synthetic peptide, Gly-Pro-Arg-Pro, in the preparation of thrombin-degranulated rabbit platelets.
Harfenist EJ; Guccione MA; Packham MA; Mustard JF
Blood; 1982 May; 59(5):952-5. PubMed ID: 7074221
[TBL] [Abstract][Full Text] [Related]
59. Platelet sialic acid and platelet survival after aggregation by ADP.
Packham MA; Guccione MA; Kinlough-Rathbone RL; Mustard JF
Blood; 1980 Nov; 56(5):876-80. PubMed ID: 7426751
[TBL] [Abstract][Full Text] [Related]
60. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
